Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testing for gene-environment interaction under exposure misspecification.

Biometrics·2017
Same author

Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer.

Molecular carcinogenesis·2017
Same author

Updating the "Risk Index": A systematic review and meta-analysis of occupational injuries and work schedule characteristics.

Chronobiology international·2017
Same author

Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population.

Carcinogenesis·2017
Same author

Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients.

Oncotarget·2017
Same author

Common <i>TDP1</i> Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium.

Clinical cancer research : an official journal of the American Association for Cancer Research·2017

Related Experiment Video

Updated: Jun 25, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

A structured exercise program for patients with advanced non-small cell lung cancer.

Jennifer S Temel1, Joseph A Greer, Sarah Goldberg

  • 1Massachusetts General Hospital, Boston, Massachusetts 02114, USA. jtemel@partners.org

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|March 12, 2009
PubMed
Summary

Structured exercise programs show promise for improving lung cancer symptoms, but adherence is a challenge. Further research into community-based or shorter interventions is recommended for advanced non-small cell lung cancer patients.

More Related Videos

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Related Experiment Videos

Last Updated: Jun 25, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Area of Science:

  • Oncology
  • Exercise Physiology
  • Rehabilitation

Background:

  • Exercise benefits cancer patients, but its role in lung cancer is understudied.
  • Feasibility, efficacy, and safety of exercise for advanced non-small cell lung cancer (NSCLC) patients remain unclear.

Purpose of the Study:

  • To assess the feasibility of a hospital-based exercise program for advanced NSCLC patients.
  • To evaluate the impact of exercise on functional capacity, strength, quality of life, and symptoms in this population.

Main Methods:

  • 25 advanced NSCLC patients (ECOG 0-1) participated in an 8-week program of twice-weekly aerobic and strength training.
  • Feasibility was measured by adherence (completing sessions).
  • Secondary outcomes included 6-minute walk test, muscle strength, quality of life, and symptom/fatigue scales.

Main Results:

  • 44% of patients completed all 16 exercise sessions; 24% attended at least 6 sessions.
  • Patients who completed the program showed significant improvement in lung cancer symptoms.
  • No decline in functional capacity (6-minute walk test) or muscle strength was observed.

Conclusions:

  • While feasible for some, high adherence to this structured exercise program was not achieved in advanced NSCLC patients.
  • Completed exercise led to symptom improvement, suggesting potential benefits.
  • Community-based or shorter exercise interventions may be more suitable for this patient group.